Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

SLC35F2 gene

Known as: FLJ13018, SLC35F2, solute carrier family 35 member F2 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background Many studies have shown that solute carrier family 35 member F2 (SLC35F2) plays a key role in the biological processes… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
2018
2018
Solute carrier family members control essential physiological functions and are tightly linked to human diseases. Solute carrier… Expand
2017
2017
202Background: Recent clinical studies have taken advantage of the dichotomous ability of androgen receptor signaling to elicit… Expand
2017
2017
Androgen receptor (AR) signaling is fundamental to prostate cancer and is the dominant therapeutic target in metastatic disease… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2017
2017
Androgen receptor (AR) signaling is fundamental to prostate cancer and is the dominant therapeutic target in metastatic disease… Expand
2016
2016
Resistance formation after initial therapy response (acquired resistance) is common in high-risk neuroblastoma patients. YM155 is… Expand
2013
2013
BackgroundTo investigate the effects of RNA interference-mediated downregulation of Human Solute Carrier Family 35 member F2… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2011
2011
Homo sapiens solute carrier family 35 member F2 (SLC35F2) is highly homologous to the lung squamous cell cancer-related gene… Expand
  • table I
  • table II
  • figure 1
  • table III
  • table IV
2008
2008
In the central nervous system, a constant microenvironment required for neuronal cell activity is maintained by the blood—brain… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5